Three numbers from delivered engagements. Every claim traced to source.
The answers to your hardest scientific questions already exist — scattered across journals, disciplines, and species boundaries that no single researcher reads together. A gene editing lab publishes findings that the immunotherapy team across the hall would recognize as transformative. Two of your own published papers contain a contradiction with millions of dollars in implications. Nobody sees it because nobody holds all the pieces at once.
This fragmentation has a price. Failed trials that published data could have predicted. Research directions that dead-end years later. And discoveries that sit dormant — not because the science failed, but because it never found the right context.
AI technologists can evaluate architecture. Only specialists with decades of field experience can judge whether a finding is biologically plausible, methodologically sound, and clinically meaningful. The validations below come from the people whose lifetime work positions them to authenticate the work — not us claiming, them confirming.
Everyone has AI. AI is infrastructure, like electricity. What ASI does is not “use AI better.” We operate upstream — at the level of what to ask, how to verify, and when to trust the answer. The methodology is the product. The intelligence speaks for itself. That upstream position is also why operators, advisors, and partners with their own client lanes find a fit — the methodology layers under existing commercialization, M&A, and academic-IP work.
Four independent competitive analyses found no company selling what we sell — packaged novel scientific hypotheses with evidence provenance at consulting-tier pricing. The space appears vacant.
Our system does not generate facts. It generates evidence-based hypotheses that domain experts authenticate — the symbiosis between methodology and field expertise is the architecture. Applied Symbiotic Intelligence is the name because the symbiosis is the mechanism.
Three co-founders. Zero external funding. A methodology that emerged through years of first-principles convergence — lived experience that cannot be reverse-engineered from the outputs alone. Seven patent-pending applications documenting the architecture. Domain experts at multiple institutions have authenticated the work as something they have not seen elsewhere.
Your published papers already contain breakthroughs nobody has connected.
We find them. Every finding traced to its source. Every hypothesis stress-tested before you see it. Engagements begin with a scoped Discovery Pilot — structured, priced, and delivered in 1–2 weeks.